Bookmark

Add to MyYahoo RSS

Pfizer News

News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.

17 hrs ago | Bloomberg

Puma's Auerbach Gained on Pfizer's Breast Drug Retreat

Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Pfizer, Science / Technology, Health, Breast Cancer, Healthcare Law, Law, Johnson and Johnson

18 hrs ago | Forbes.com

The Debate On Shareholder Value Gets Political

Two months ago, I explained how the single-minded pursuit of making money for shareholders has driven companies like Pfizer [PFE] to try to lower their taxes by moving their legal headquarters to another country-the so-called practice of "inversion"-even if the move harms customers and patients: Does Pfizer Hate Patients? .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Business News

Thu Jul 24, 2014

Seeking Alpha

JNJ: Another Win Added To The Earnings Season

JNJ reported a 2.4% increase in its consumer segment revenue, led by a 9% rise from over the counter drugs, including Tylenol.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Aria Systems, Washington, PA, Fort Washington, PA

SFGate

This Eye-Popping Chart Of Ex-US Companies Shows Why People Are...

This Eye-Popping Chart Of Ex-US Companies Shows Why People Are Freaking Out About 'Tax Inversions' A tax inversion is a corporate merger strategy that involves a company based in one country, say the U.S., acquires another company based somewhere else, say the U.K., and following the deal moves its tax base to enjoy a lower corporate tax rate.

Comment?

Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech

Reuters

UPDATE 3-Lilly beats forecasts, vows to remain independent

Eli Lilly and Co's quarterly revenue plunged due to generic competition for its Cymbalta depression drug and its Evista osteoporosis treatment, but cost controls helped earnings beat forecasts.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Osteoporosis, Health, Schizophrenia

Fox News

Obama Aims at 'Unpatriotic' Corporate Inversions

President Barack Obama is taking direct aim at the rising number of U.S. companies using international mergers to relocate their headquarters overseas in an effort to avoid paying U.S. corporate taxes.

Comment?

Related Topix: US Politics, US News, Barack Obama, Biotech, Medicine, Healthcare Industry, Business News

SchaeffersResearch.com

Most Active Options Update: Pfizer Inc.

Calls are the options of choice on Pfizer Inc. today, with roughly 10,000 calls and 3,500 puts changing hands so far.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Day Trading, Financial Markets, Personal Finance

Bloomberg

Bristol-Myers Tops Earnings Estimates on Drug Sales

Bristol-Myers Squibb Co. , the maker of the anti-psychotic drug Abilify, reported second-quarter profit that topped analysts' estimates on sales of its cancer medicine Yervoy and blood thinner Eliquis.

Comment?

Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Hepatitis, Health, US News

American Reporter

One Woman's WorldLIFE Can Become Too Quiet

The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose.

Comment?

Related Topix: Financial Markets, Personal Finance, Retirement, Microsoft, Startups, Biotech, Medicine, Healthcare Industry

Wed Jul 23, 2014

Seeking Alpha

Today's Market: Biotech Names Rallying Today

Our regular readers know that we have been using the idea of buying on the dips and searching for value while investing in this bull market the past few years.

Comment?

Related Topix: Biotech, Science / Technology, Medicine, Pfizer, Excaliard Pharmaceuticals, Healthcare Industry, Foldrx Pharmaceuticals

Daily Record

Prempro lawyers agree to settle $62 million fee fight

Lawyers who battled Pfizer Inc. for more than a decade over women's cancers linked to the company's Prempro menopause drug settled a rare public dispute over $62 million in fees.

Comment?

Related Topix: Medicine, Prempro, Estrogen/Progestin (generic), Biotech, Healthcare Industry, Cancer, Health, Menopause, Breast Cancer, Arkansas

Seeking Alpha

Too Early To Tell For Atara Biotherapeutics IPO

ATRA, a clinical-stage biopharmaceutical firm, engaged in the development of treatments for muscle wasting conditions, plans to raise $75.0 million in its upcoming IPO.

Comment?

Related Topix: Venture Capital, Emerging Technology, San Mateo County, CA, Brisbane, CA, Biotech, Medicine, Amgen, Healthcare Industry

Forbes.com

Wednesday's ETF with Unusual Volume: PPH

The Pharmaceutical ETF is seeing unusually high volume in afternoon trading Wednesday, with over 377,000 shares traded versus three month average volume of about 101,000.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, GlaxoSmithKline, Financial Markets

Barron's

Puma Biotechnolgy Triples on Trial Data, Still Room to Run?

Although we did not see a positive neratinib ExteNET outcome in adjuvant breast cancer as a complete surprise, we believe the magnitude of benefit is among best-case scenarios that could be envisioned.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Breast Cancer, Biotech, Healthcare Industry

BioSpace

Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials

July 23, 2014 By Renee Morad , BioSpace.com Breaking News Staff Puma Biotechnology Inc. announced an amendment to its licensing agreement with Pfizer regarding its investigational cancer drug neratinib, or PB272.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Startups, BioSpace.com, Media, Fox Filmed Entertainment

GuruFocus.com

Pfizer: A Fairly Valued Stock

In a previous article we saw that Pfizer Inc. was the principal holding in Zacks Investment ManagementA s Portfolio.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Tue Jul 22, 2014

Reuters

UPDATE 1-Puma says cancer drug meets trial goal, shares soar

Shares of the company, which doesn't have any drug in the market, tripled to $176.94 in extended trading.

Comment?

Related Topix: Medicine, Health, Breast Cancer, Biotech, Healthcare Industry, Lung Cancer

Fox News

FT: 25 More Firms May Seek Tax Breaks Overseas

A top Democrat warned on Tuesday a recent string of so-called tax inversions could foreshadow future moves as U.S. firms look to dodge American taxes.

Comment?

Related Topix: Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech, Business News

Forbes.com

No Need To Envy Tax-Inversion Takeovers: Better Tax Deal Awaits

Watching big pharmaceutical companies and other major U.S. corporations line up to make foreign acquisitions that will bring them a low-tax haven as headquarters, a middle market CEO/owner/entrepreneur could easily become jealous.

Comment?

Related Topix: Walgreens, Retail, Medtronic, Medicine, Medical Equipment, Healthcare Industry, Biotech

AmericanBankingNews.com

Pfizer Given Average Rating of "Buy" by Analysts

Shares of Pfizer have received a consensus rating of "Buy" from the seventeen ratings firms that are covering the company, Stock Ratings Network reports .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Investment Banking, Financial Services, Jefferies Group, Investment Services

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••